| 000 | 01408 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250513190915.0 | ||
| 264 | 0 | _c19990831 | |
| 008 | 199908s 0 0 eng d | ||
| 022 | _a0364-5134 | ||
| 024 | 7 |
_a10.1002/1531-8249(199908)46:2<197::aid-ana9>3.0.co;2-p _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLi, D K | |
| 245 | 0 | 0 |
_aMagnetic resonance imaging results of the PRISMS trial: a randomized, double-blind, placebo-controlled study of interferon-beta1a in relapsing-remitting multiple sclerosis. Prevention of Relapses and Disability by Interferon-beta1a Subcutaneously in Multiple Sclerosis. _h[electronic resource] |
| 260 |
_bAnnals of neurology _cAug 1999 |
||
| 300 |
_a197-206 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInterferon beta-1a |
| 650 | 0 | 4 |
_aInterferon-beta _xtherapeutic use |
| 650 | 0 | 4 | _aMagnetic Resonance Imaging |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMultiple Sclerosis _xpathology |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRecurrence |
| 700 | 1 | _aPaty, D W | |
| 773 | 0 |
_tAnnals of neurology _gvol. 46 _gno. 2 _gp. 197-206 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/1531-8249(199908)46:2<197::aid-ana9>3.0.co;2-p _zAvailable from publisher's website |
| 999 |
_c10401613 _d10401613 |
||